Literature DB >> 10474637

An analysis of the determinants of anaemia in pregnant women in rural Malawi--a basis for action.

F H Verhoeff1, B J Brabin, L Chimsuku, P Kazembe, R L Broadhead.   

Abstract

Haematological data are presented on 4104 pregnant women attending the antenatal-care facilities of two hospitals in a rural area in southern Malawi. In this area, malaria transmission is perennial and there is a high prevalence of HIV infection. The local women are exposed to drought and food shortages but experience high fertility rates. Mean (S.D.) haemoglobin (Hb) concentration was significantly lower in the primigravidae [8.7 (1.60 g/dl] than in the secundigravidae [9.1 (1.5) g/dl; P < 0.0001] or multigravidae [9.2 (1.5) g/dl; P < 0.0001]. Primigravidae also experienced significantly more iron deficiency and malaria than secundi- or multi-gravidae. For all parity groups, the lowest mean Hb levels were observed between 26-30 weeks' gestation. In primigravidae peak prevalence of malaria occurred between 16-20 weeks' gestation (38.6%) and peak prevalence of moderately severe anaemia (< 8 g Hb/dl) between 26-30 weeks' (35.7%). Multigravidae showed little variation in the prevalence of anaemia, iron deficiency and malaria with gestational age. Peak prevalences of malaria were observed in April, in the post-rainy season, with values of 51.4%, 56.0% and 25.3% for primi-, secundi- and multi-gravidae, respectively. Peak prevalences of iron deficiency occurred between April and May and those of moderately severe anaemia between May and June. Mean Hb was lower in adolescent primigravidae than in any other group of pregnant women [8.6 (1.5) g/dl], including the non-adolescent primigravidae [8.9 (1.6) g/dl; P = 0.008]. Other factors significantly associated with increased risk of moderately severe anaemia in primigravidae were illiteracy and poor nutritional status (i.e. body mass index < 18.5 kg/m2 and mid-upper-arm circumference < 23 cm). After forward, step-wise, regression analysis of relative risk (RR) factors and their 95% confidence intervals (CI), variables associated with an increased risk for moderately severe anaemia were iron deficiency (RR = 4.2; CI = 3.0-6.0) and malaria parasitaemia (RR = 1.9; CI = 1.3-2.7) in primigravidae, iron deficiency (RR = 4.1; CI = 2.7-6.3) and mid-upper-arm-circumference < 23 cm (RR = 1.8; CI = 1.1-3.0) in secundigravidae, and iron deficiency in multigravidae (RR = 3.1; CI = 4.3-6.9).

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10474637     DOI: 10.1080/00034989958609

Source DB:  PubMed          Journal:  Ann Trop Med Parasitol        ISSN: 0003-4983


  16 in total

1.  Intermittent preventive treatment with sulfadoxine-pyrimethamine against malaria and anemia in pregnant women.

Authors:  Nana O Wilson; Fatou K Ceesay; Samuel A Obed; Andrew A Adjei; Richard K Gyasi; Patricia Rodney; Yassa Ndjakani; Winston A Anderson; Naomi W Lucchi; Jonathan K Stiles
Journal:  Am J Trop Med Hyg       Date:  2011-07       Impact factor: 2.345

Review 2.  Anaemia In Pregnancy In Malawi- A Review.

Authors:  Sujeevani Munasinghe; Nynke van den Broek
Journal:  Malawi Med J       Date:  2006-12       Impact factor: 0.875

3.  The effect of timing and frequency of Plasmodium falciparum infection during pregnancy on the risk of low birth weight and maternal anemia.

Authors:  Linda Kalilani; Innocent Mofolo; Marjorie Chaponda; Stephen J Rogerson; Steven R Meshnick
Journal:  Trans R Soc Trop Med Hyg       Date:  2010-03-06       Impact factor: 2.184

4.  Prevalence of intermittent preventive treatment with sulphadoxine-pyrimethamine (IPTp-SP) use during pregnancy and other associated factors in Sekondi-Takoradi, Ghana.

Authors:  Verner N Orish; Onyekachi S Onyeabor; Johnson N Boampong; Richmond Afoakwah; Ekene Nwaefuna; Samuel Acquah; Adekunle O Sanyaolu; Nnaemeka C Iriemenam
Journal:  Afr Health Sci       Date:  2015-12       Impact factor: 0.927

5.  Antibodies that inhibit Plasmodium falciparum adhesion to chondroitin sulfate A are associated with increased birth weight and the gestational age of newborns.

Authors:  Patrick E Duffy; Michal Fried
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

Review 6.  Dapsone therapy for malaria during pregnancy: maternal and fetal outcomes.

Authors:  Bernard J Brabin; Teunis A Eggelte; Monica Parise; Francine Verhoeff
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

7.  Zinc erythrocyte protoporphyrin as marker of malaria risk in pregnancy - a retrospective cross-sectional and longitudinal study.

Authors:  Edward L Senga; Gibby Koshy; Bernard J Brabin
Journal:  Malar J       Date:  2012-07-30       Impact factor: 2.979

8.  ABO blood group phenotypes influence parity specific immunity to Plasmodium falciparum malaria in Malawian women.

Authors:  Edward Senga; Maria-Paz Loscertales; K E B Makwakwa; George N Liomba; Charles Dzamalala; Peter N Kazembe; Bernard J Brabin
Journal:  Malar J       Date:  2007-08-03       Impact factor: 2.979

Review 9.  Monitoring and evaluation of malaria in pregnancy - developing a rational basis for control.

Authors:  Bernard J Brabin; Marian Warsame; Marian Wasame; Ulrika Uddenfeldt-Wort; Stephanie Dellicour; Jenny Hill; Sabine Gies
Journal:  Malar J       Date:  2008-12-11       Impact factor: 2.979

10.  Could a simple antenatal package combining micronutritional supplementation with presumptive treatment of infection prevent maternal deaths in sub-Saharan Africa?

Authors:  Simon M Collin; Rebecca F Baggaley; Rudiger Pittrof; Veronique Filippi
Journal:  BMC Pregnancy Childbirth       Date:  2007-05-23       Impact factor: 3.007

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.